256 related articles for article (PubMed ID: 26631311)
1. [T2HD Study. Oral anticoagulants and antiplatelet agents: Practices, benefits, and risks in the chronic hemodialysis population. Observational data].
Martin A; Thilly N; Ayav C; Clerc-Urmes I; Held P; Frimat L; Peters NO
Nephrol Ther; 2016 Jun; 12(3):156-65. PubMed ID: 26631311
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet and oral anticoagulant therapies in chronic hemodialysis patients: prescribing practices and bleeding risk.
Collette C; Clerc-Urmès I; Laborde-Castérot H; Frimat L; Ayav C; Peters N; Martin A; Agrinier N; Thilly N
Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):935-43. PubMed ID: 27133538
[TBL] [Abstract][Full Text] [Related]
3. Preventing arteriovenous shunt failure in hemodialysis patients: a population-based cohort study.
Fan PY; Lee CC; Liu SH; Li IJ; Weng CH; Tu KH; Hsieh MY; Kuo CF; Chang TY; Tian YC; Yang CW; Wu HH
J Thromb Haemost; 2019 Jan; 17(1):77-87. PubMed ID: 30472783
[TBL] [Abstract][Full Text] [Related]
4. Influence of antiplatelet medications on bleeding events in hemodialysis patients.
Daimon S; Terai H
Ther Apher Dial; 2011 Oct; 15(5):454-9. PubMed ID: 21974698
[TBL] [Abstract][Full Text] [Related]
5. Outcomes associated with combined antiplatelet and anticoagulant therapy.
Johnson SG; Rogers K; Delate T; Witt DM
Chest; 2008 Apr; 133(4):948-54. PubMed ID: 18198244
[TBL] [Abstract][Full Text] [Related]
6. Management of antiplatelet and anticoagulant therapy for endoscopic procedures: Introduction to novel oral anticoagulants.
González Bárcenas ML; Pérez Aisa Á
Rev Esp Enferm Dig; 2016 Feb; 108(2):89-96. PubMed ID: 26838491
[TBL] [Abstract][Full Text] [Related]
7. [Platelet antiaggregation and hemorrhagic risk in hemodialysis].
Sánchez Perales MC; Vázquez E; García Cortés MJ; Borrego FJ; Borrego J; Pérez del Barrio P; Liébana A; Gil JM; Viedma G; Pérez Bañasco V
Nefrologia; 2002; 22(5):456-62. PubMed ID: 12497747
[TBL] [Abstract][Full Text] [Related]
8. [Bridging: Perioperative management of chronic anticoagulation or antiplatelet therapy].
Nowak-Göttl U; Langer F; Limperger V; Mesters R; Trappe RU
Dtsch Med Wochenschr; 2014 Jun; 139(24):1301-6. PubMed ID: 24892468
[TBL] [Abstract][Full Text] [Related]
9. Complications after placement of an intracoronary stent: nursing implications.
Dabbs AD; Chambers CE; Macauley K
Am J Crit Care; 1998 Mar; 7(2):117-22. PubMed ID: 9509225
[TBL] [Abstract][Full Text] [Related]
10. [Use of oral anticoagulants to prevent central venous catheter-related thrombosis in hemodialysis].
Mandolfo S; Gallieni M
G Ital Nefrol; 2010; 27(5):490-7. PubMed ID: 20922680
[TBL] [Abstract][Full Text] [Related]
11. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
[TBL] [Abstract][Full Text] [Related]
12. Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.
Chan KE; Edelman ER; Wenger JB; Thadhani RI; Maddux FW
Circulation; 2015 Mar; 131(11):972-9. PubMed ID: 25595139
[TBL] [Abstract][Full Text] [Related]
13. Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry--GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry--Get With the Guidelines).
Kadakia MB; Desai NR; Alexander KP; Chen AY; Foody JM; Cannon CP; Wiviott SD; Scirica BM;
JACC Cardiovasc Interv; 2010 Nov; 3(11):1166-77. PubMed ID: 21087753
[TBL] [Abstract][Full Text] [Related]
14. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
15. A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons.
Brown DG; Wilkerson EC; Love WE
J Am Acad Dermatol; 2015 Mar; 72(3):524-34. PubMed ID: 25486915
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet medications in hemodialysis patients: a systematic review of bleeding rates.
Hiremath S; Holden RM; Fergusson D; Zimmerman DL
Clin J Am Soc Nephrol; 2009 Aug; 4(8):1347-55. PubMed ID: 19578002
[TBL] [Abstract][Full Text] [Related]
17. Contemporary Use of Oral Antithrombotic Agents: Focus on Dual and Triple Therapeutic Approaches.
Jenkins AT; Kantorovich A; Burman L
Pharmacotherapy; 2017 Dec; 37(12):1545-1564. PubMed ID: 28981961
[TBL] [Abstract][Full Text] [Related]
18. Management of bleeding in patients using antithrombotic agents: prediction, prevention, protection and problem-oriented intervention.
Scharf RE
Hamostaseologie; 2009 Nov; 29(4):388-98. PubMed ID: 19882082
[TBL] [Abstract][Full Text] [Related]
19. Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy.
Sra S; Tan MK; Mehta SR; Fisher HN; Déry JP; Welsh RC; Eisenberg MJ; Overgaard CB; Rose BF; Siega AJ; Cheema AN; Wong BY; Henderson MA; Lutchmedial S; Lavi S; Goodman SG; Yan AT;
Am Heart J; 2016 Oct; 180():82-9. PubMed ID: 27659886
[TBL] [Abstract][Full Text] [Related]
20. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F
G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
